{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:07:38Z","timestamp":1776406058189,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Basic Research Program (Natural Science) Project of Qiandongnan Prefecture","award":["No. (2025)0011"],"award-info":[{"award-number":["No. (2025)0011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00228-026-04016-8","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:39:32Z","timestamp":1772761172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of transporter gene polymorphisms and valproate co-medication on the steady-state disposition of lamotrigine and their effect on efficacy in adults with epilepsy"],"prefix":"10.1007","volume":"82","author":[{"given":"Changsong","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"4","key":"4016_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G et al (2017) ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58(4):512\u2013521","journal-title":"Epilepsia"},{"issue":"5","key":"4016_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1528-1157.1986.tb03573.x","volume":"27","author":"MJ Leach","year":"1986","unstructured":"Leach MJ, Marden CM, Miller AA (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27(5):490\u2013497","journal-title":"Epilepsia"},{"issue":"4","key":"4016_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/FTD.0b013e31817fd4d4","volume":"30","author":"N Rivas","year":"2008","unstructured":"Rivas N, Buelga DS, Elger CE et al (2008) Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy. Ther Drug Monit 30(4):483\u2013489","journal-title":"Ther Drug Monit"},{"issue":"10","key":"4016_CR4","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/j.1528-1167.2011.03217.x","volume":"52","author":"H Arif","year":"2011","unstructured":"Arif H, Svoronos A, Resor SR Jr. et al (2011) The effect of age and comedication on lamotrigine clearance, tolerability, and efficacy. Epilepsia 52(10):1905\u20131913","journal-title":"Epilepsia"},{"issue":"4","key":"4016_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s13318-024-00894-4","volume":"49","author":"J Yang","year":"2024","unstructured":"Yang J, Wang J, Ning L et al (2024) Influence of UGT2B7, UGT1A4 and ABCG2 Polymorphisms on the Pharmacokinetics and Therapeutic Efficacy of Lamotrigine in Patients with Epilepsy. Eur J Drug Metab Pharmacokinet 49(4):437\u2013447","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"6","key":"4016_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1124\/dmd.106.009340","volume":"34","author":"A Rowland","year":"2006","unstructured":"Rowland A, Elliot DJ, Williams JA et al (2006) In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction. Drug Metab Dispos 34(6):1055\u20131062","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"4016_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/FTD.0b013e3181ceecc6","volume":"32","author":"M Blanca Sanchez","year":"2010","unstructured":"Blanca Sanchez M, Herranz JL, Leno C et al (2010) UGT2B7_-161C\u2009>\u2009T Polymorphism Is Associated With Lamotrigine Concentration-to-Dose Ratio in a Multivariate Study. Ther Drug Monit 32(2):177\u2013184","journal-title":"Ther Drug Monit"},{"issue":"1\u20132","key":"4016_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2011.01.016","volume":"95","author":"MI Gulcebi","year":"2011","unstructured":"Gulcebi MI, Ozkaynakci A, Goren MZ et al (2011) The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy. Epilepsy Res 95(1\u20132):1\u20138","journal-title":"Epilepsy Res"},{"issue":"2","key":"4016_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/bcpt.13120","volume":"124","author":"SC Kim","year":"2019","unstructured":"Kim SC, Kim MG (2019) Meta-analysis of the Influence of UGT Genetic Polymorphisms on Lamotrigine Concentration. Basic Clin Pharmacol Toxicol 124(2):163\u2013169","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"7","key":"4016_CR10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","volume":"49","author":"PN Patsalos","year":"2008","unstructured":"Patsalos PN, Berry DJ, Bourgeois BF et al (2008) Antiepileptic drugs\u2013best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49(7):1239\u20131276","journal-title":"Epilepsia"},{"issue":"8","key":"4016_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00228-014-1690-1","volume":"70","author":"Y Chang","year":"2014","unstructured":"Chang Y, Yang LY, Zhang MC et al (2014) Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China. Eur J Clin Pharmacol 70(8):941\u2013946","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"4016_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.dmpk.2014.12.007","volume":"30","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liang M, Dong Y et al (2015) Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy. Drug Metab Pharmacokinet 30(3):209\u2013213","journal-title":"Drug Metab Pharmacokinet"},{"key":"4016_CR13","doi-asserted-by":"crossref","unstructured":"Klarica Domjanovi\u0107 I, Lovri\u0107 M, Trkulja V et al (2018)\u00a0Interaction between ABCG2 421CA polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy. Br J Clin Pharmacol. 84(9):2106\u20132119","DOI":"10.1111\/bcp.13646"},{"issue":"6","key":"4016_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/FTD.0000000000000563","volume":"40","author":"Y Chen","year":"2018","unstructured":"Chen Y, Xu S, Wang Z et al (2018) A Population Pharmacokinetic-Pharmacogenetic Model of Lamotrigine in Chinese Children With Epilepsy. Ther Drug Monit 40(6):730\u2013737","journal-title":"Ther Drug Monit"},{"issue":"2","key":"4016_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/bcp.12984","volume":"82","author":"D Milosheska","year":"2016","unstructured":"Milosheska D, Lorber B, Vovk T et al (2016) Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters. Br J Clin Pharmacol 82(2):399\u2013411","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"4016_CR16","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00228-012-1449-5","volume":"69","author":"N Singkham","year":"2013","unstructured":"Singkham N, Towanabut S, Lertkachatarn S et al (2013) Influence of the UGT2B7 -161C\u2009>\u2009T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients. Eur J Clin Pharmacol 69(6):1285\u20131291","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"4016_CR17","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00228-015-1925-9","volume":"71","author":"L Liu","year":"2015","unstructured":"Liu L, Zhao L, Wang Q et al (2015) Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7-161C\u2009>\u2009T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children. Eur J Clin Pharmacol 71(11):1341\u20131347","journal-title":"Eur J Clin Pharmacol"},{"key":"4016_CR18","doi-asserted-by":"crossref","unstructured":"Wang Z-z, Zhang Y-f, Huang W-c et al (2019) Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy. Front Pharmacol. 10","DOI":"10.3389\/fphar.2019.00832"},{"key":"4016_CR19","doi-asserted-by":"crossref","unstructured":"Grewal GK, Kukal S, Kanojia N et al (2017) In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2. 22(10):832","DOI":"10.3390\/molecules22101484"},{"issue":"7","key":"4016_CR20","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/epi.13037","volume":"56","author":"M Rubinchik-Stern","year":"2015","unstructured":"Rubinchik-Stern M, Shmuel M, Eyal S (2015) Antiepileptic drugs alter the expression of placental carriers: An in vitro study in a human placental cell line. Epilepsia 56(7):1023\u20131032","journal-title":"Epilepsia"},{"key":"4016_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.reprotox.2020.04.077","volume":"96","author":"N Jinno","year":"2020","unstructured":"Jinno N, Furugen A, Kurosawa Y et al (2020) Effects of single and repetitive valproic acid administration on the gene expression of placental transporters in pregnant rats: An analysis by gestational period. Reproductive Toxicol (Elmsford NY) 96:47\u201356","journal-title":"Reproductive Toxicol (Elmsford NY)"},{"issue":"25","key":"4016_CR22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","volume":"337","author":"J Motte","year":"1997","unstructured":"Motte J, Trevathan E, Arvidsson JFV et al (1997) Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 337(25):1807\u20131812","journal-title":"N Engl J Med"},{"issue":"12","key":"4016_CR23","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/bmc.3789","volume":"30","author":"J Dupouey","year":"2016","unstructured":"Dupouey J, Doudka N, Belo S et al (2016) Simultaneous determination of four antiepileptic drugs in human plasma samples using an ultra-high-performance liquid chromatography tandem mass spectrometry method and its application in therapeutic drug monitoring. Biomed Chromatogr 30(12):2053\u20132060","journal-title":"Biomed Chromatogr"},{"key":"4016_CR24","doi-asserted-by":"crossref","unstructured":"Tomori Y, Suzuki T, Mihara K (2024) Effect of Genetic Polymorphisms of ABCB1, ABCG2, and SLC22A1 on the Steady-State Plasma Concentrations of Lamotrigine in Treatment-Resistant Depressed Patients Treated With Lamotrigine Augmentation Therapy. Clin Neuropharmacol. 47(5):163\u2013167","DOI":"10.1097\/WNF.0000000000000607"},{"key":"4016_CR25","doi-asserted-by":"publisher","first-page":"1651898","DOI":"10.3389\/fphar.2025.1651898","volume":"16","author":"HA Alhaj","year":"2025","unstructured":"Alhaj HA, Samara J, Alnamous A et al (2025) Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions. Front Pharmacol 16:1651898","journal-title":"Front Pharmacol"},{"issue":"7","key":"4016_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/1440-1681.12584","volume":"43","author":"AO Baldoni","year":"2016","unstructured":"Baldoni AO, Freitas-Lima P, de Santi Ferreira FI et al (2016) An investigation of the influence of patient-related factors and comedications on lamotrigine clearance in patients with epilepsy. Clin Exp Pharmacol Physiol 43(7):685\u2013689","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4016_CR27","doi-asserted-by":"crossref","unstructured":"Chigutsa E, Her L, Ma X et al (2025) A Pharmacometric Method for Quantitative Determination of Improvement in Body Composition and Characterization of the Exposure-Response Relationship during Treatment of Obesity with Tirzepatide.Clin Pharmacol Ther. 118(6):1489\u20131498","DOI":"10.1002\/cpt.3750"},{"issue":"7","key":"4016_CR28","first-page":"638","volume":"11","author":"J Tamargo","year":"2025","unstructured":"Tamargo J, Delp\u00f3n E (2025) Sex-related differences in cardiovascular pharmacotherapy: fiction or fact? Why can\u2019t we see evidence? 11(7):638\u2013652","journal-title":"Why can\u2019t we see evidence?"},{"key":"4016_CR29","doi-asserted-by":"publisher","first-page":"106728","DOI":"10.1016\/j.eplepsyres.2021.106728","volume":"176","author":"ML Wang","year":"2021","unstructured":"Wang ML, Wang HX, Zhao MM et al (2021) Redefining the age-specific therapeutic ranges of lamotrigine for patients with epilepsy: A step towards optimizing treatment and increasing cost-effectiveness. Epilepsy Res 176:106728","journal-title":"Epilepsy Res"},{"key":"4016_CR30","doi-asserted-by":"crossref","unstructured":"Couper RG, Espino PH (2025) Effects of antiseizure medications on sexual hormones and functions in males with epilepsy: A systematic review and meta-analysis. Epilepsia. 66(8):2639\u20132656","DOI":"10.1111\/epi.18436"},{"issue":"1","key":"4016_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eplepsyres.2009.02.011","volume":"85","author":"C Fotopoulou","year":"2009","unstructured":"Fotopoulou C, Kretz R, Bauer S et al (2009) Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period. Epilepsy Res 85(1):60\u201364","journal-title":"Epilepsy Res"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04016-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04016-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04016-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:37:28Z","timestamp":1776404248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04016-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4016"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04016-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol adhered to the principles of the Declaration of Helsinki and received approval from the institutional Ethics Committee (approval number: 2023-LS-205). Informed consent was obtained from all participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}